☰

Empresas y finanzas

ADVENTRX to Present at Annual Euro-Biotech Forum


    ADVENTRX Pharmaceuticals, Inc. (AMEX:ANX) announced
    today that Brian M. Culley, vice president of business development,
    will present a corporate overview at the 13th Annual Euro-Biotech
    Forum on June 29 at 2:45 p.m. Central European Summer Time. The
    Euro-Biotech Forum is an industry partnering meeting for American and
    European life science companies. The conference takes place June
    27-29, 2006, at the Westin Paris. More information about the
    conference can be found on the conference Web site at
    http://www.eurobiotechforum.com.

    About ADVENTRX

    ADVENTRX Pharmaceuticals is a biopharmaceutical research and
    development company focused on introducing treatments for cancer and
    infectious disease that surpass the performance and safety of existing
    drugs, by addressing significant problems such as drug metabolism,
    toxicity, bioavailability and resistance. More information can be
    found on the Company's Web site at www.adventrx.com.

    Forward-Looking Statement

    This press release contains forward-looking statements, within the
    meaning of the "safe harbor" provisions of the Private Securities
    Litigation Reform Act of 1995, regarding ADVENTRX. Such statements are
    made based on management's current expectations and beliefs. Actual
    results may vary from those currently anticipated based upon a number
    of factors, including uncertainties inherent in the drug development
    process, the timing and success of clinical trials, the validity of
    research results, and the receipt of necessary approvals from the FDA
    and other regulatory agencies. For a discussion of such risks and
    uncertainties, which could cause actual results to differ from those
    contained in the forward-looking statements regarding ADVENTRX, see
    the section titled "Risk Factors" in ADVENTRX's last annual report on
    Form 10-K and its Quarterly Reports on Form 10-Q, as well as other
    reports that ADVENTRX files from time to time with the Securities and
    Exchange Commission. All forward-looking statements regarding ADVENTRX
    are qualified in their entirety by this cautionary statement. ADVENTRX
    undertakes no obligation to release publicly any revisions to
    forward-looking statements to reflect events or circumstances which
    occur after the date hereof.